Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients
Alberto Polimeni, Isabella Leo, Carmen Spaccarotella, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 7, pp. 475-495
Open Access | Times Cited: 254
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
Douglas B. Kell, Gert Jacobus Laubscher, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 4, pp. 537-559
Open Access | Times Cited: 215
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement
Mohammad Sayyadi, Saeed Hassani, Mahmood Shams, et al.
Annals of Hematology (2023) Vol. 102, Iss. 6, pp. 1307-1322
Open Access | Times Cited: 27
Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease
Thomas Girard, Lilian Antunes, Nan Zhang, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 3, pp. 629-638
Open Access | Times Cited: 24
Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic
Benjamin Marchandot, Antonin Trimaille, Anaïs Curtiaud, et al.
Journal of Thrombosis and Thrombolysis (2020) Vol. 50, Iss. 4, pp. 799-808
Open Access | Times Cited: 51
Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes
Cheng‐Han Chen, Sheng-Wen Lin, Ching‐Fen Shen, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 509-509
Open Access | Times Cited: 36
Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammation
Giovanni Cimmino, Saverio Muscoli, Salvatore De Rosa, et al.
Journal of Cardiovascular Medicine (2023) Vol. 24, Iss. Supplement 2, pp. e156-e167
Open Access | Times Cited: 21
D-dimer testing: A narrative review
Loris Wauthier, Julien Favresse, Michaël Hardy, et al.
Advances in clinical chemistry (2023), pp. 151-223
Closed Access | Times Cited: 19
Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection
Lukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 24
Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients
David Cabrera-García, Andrea Miltiades, Peter D. Yim, et al.
International Journal of Hematology (2022) Vol. 116, Iss. 6, pp. 937-946
Open Access | Times Cited: 22
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
Assunta Di Costanzo, Ciro Indolfi, Sabato Sorrentino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11739-11739
Open Access | Times Cited: 10
Coagulopathies in Intensive Care Medicine: Balancing Act between Thrombosis and Bleeding
Friederike S. Neuenfeldt, Markus Weigand, Dania Fischer
Journal of Clinical Medicine (2021) Vol. 10, Iss. 22, pp. 5369-5369
Open Access | Times Cited: 16
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study
Emily Córneo, Rafael Garbelotto, Gabriele da Silveira Prestes, et al.
Thrombosis Journal (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Role of Acute Thrombosis in Coronavirus Disease 2019
Derek V. Gibbs, Satya Shreenivas, Kristin Hudock
Critical Care Clinics (2022) Vol. 38, Iss. 3, pp. 491-504
Open Access | Times Cited: 6
Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes
Mengdi Li, Xiaoming Wu, Jialan Shi, et al.
Endocrine (2023) Vol. 82, Iss. 1, pp. 15-27
Closed Access | Times Cited: 3
Acute Neurological Complications of Coronavirus Disease
Sanders Chang, Michael Schecht, Rajan Jain, et al.
Neuroimaging Clinics of North America (2022) Vol. 33, Iss. 1, pp. 57-68
Open Access | Times Cited: 5
Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19
Matthias H. Busch, Sjoerd A.M.E.G. Timmermans, Sander M. J. van Kuijk, et al.
Haematologica (2022) Vol. 108, Iss. 5, pp. 1417-1422
Open Access | Times Cited: 5
Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center
Laura-Monserrat Hernández-Regino, Manuel Castillejos‐López, Arnoldo Aquino‐Gálvez, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 4
Integral assays of hemostasis in hospitalized patients with COVID-19 on admission and during heparin thromboprophylaxis
А. Yu. Bulanov, E. L. Bulanova, И. Б. Симарова, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0282939-e0282939
Open Access | Times Cited: 2
Immature platelets in COVID‐19 infection
Robert W. Maitta
British Journal of Haematology (2021) Vol. 194, Iss. 3, pp. 494-495
Open Access | Times Cited: 4
Low molecular weight heparin is associated with better outcomes than unfractionated heparin for thromboprophylaxis in hospitalized COVID-19 patients: a meta-analysis
Mochamad Yusuf Alsagaff, Eka Prasetya Budi Mulia, Irma Maghfirah, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2022) Vol. 8, Iss. 8, pp. 909-918
Open Access | Times Cited: 3
The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19
Katarzyna Gryglewska-Wawrzak, Krzysztof Cienkowski, Alicja Cienkowska, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 6, pp. 245-245
Open Access | Times Cited: 1
Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients
David Cabrera-García, Andrea Miltiades, Peter D. Yim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Hemodynamic Dysfunctions in COVID-19 Patients
Rubens Barbosa Rezende
Research Society and Development (2021) Vol. 10, Iss. 12, pp. e111101220323-e111101220323
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top